Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acquired inflammatory demyelinating neuropathies.

E R Ensrud1, L S Krivickas

  • 1Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Physical Medicine and Rehabilitation Clinics of North America
|May 10, 2001
PubMed
Summary

Acquired demyelinating neuropathies are categorized by onset: acute (like Guillain-Barré syndrome) and chronic (like chronic inflammatory demyelinating polyradiculoneuropathy). This review covers their features, diagnosis, and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiepileptic drug use and rates of hip bone loss in older men: a prospective study.

Neurology·2008
Same author

Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.

The Cochrane database of systematic reviews·2008
Same author

Antiepileptic drug use increases rates of bone loss in older women: a prospective study.

Neurology·2004
Same author

Contractile properties of aging skeletal muscle.

International journal of sport nutrition and exercise metabolism·2002
Same author

Contractile properties of adjacent segments of single human muscle fibers.

Muscle & nerve·2001
Same author

Age- and gender-related differences in maximum shortening velocity of skeletal muscle fibers.

American journal of physical medicine & rehabilitation·2001

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Acquired demyelinating neuropathies present with diverse clinical courses, broadly classified into acute and chronic forms.
  • Acute neuropathies often manifest as Guillain-Barré syndrome and its subtypes.
  • Chronic neuropathies are encompassed by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and its variants.

Purpose of the Study:

  • To provide a comprehensive overview of acquired demyelinating neuropathies.
  • To discuss the clinical features, pathology, and pathogenesis of acute and chronic forms.
  • To outline diagnostic approaches, treatment strategies, rehabilitation, and prognosis.

Main Methods:

  • Literature review and synthesis of existing knowledge on acquired demyelinating neuropathies.

Related Experiment Videos

  • Discussion of clinical presentations, diagnostic criteria, and therapeutic interventions.
  • Analysis of pathological mechanisms and prognostic factors.

    • Main Results:

    • Acquired demyelinating neuropathies are systematically classified into acute (e.g., AIDP, AMAN) and chronic (CIDP and variants like MADSAM, DADS) categories.
    • Distinct clinical features, pathological findings, and pathogenetic mechanisms characterize each subtype.
    • Effective management strategies involve targeted treatments and rehabilitation tailored to the specific neuropathy.

    Conclusions:

    • Understanding the classification and distinct characteristics of acquired demyelinating neuropathies is crucial for accurate diagnosis and effective management.
    • A multidisciplinary approach encompassing clinical evaluation, diagnostics, and tailored treatment is essential for optimizing patient outcomes.
    • Further research into pathogenesis may yield novel therapeutic targets for these debilitating neurological conditions.